BIOINN - Biomedical Innovation Unit

 

Logo de Instagram Ir a instagram

  • carrusel_1
  • Carrusel_2
  • Carrusel_3
  • Carrusel_4

 

CIEMAT's Biomedical Innovation Unit is focused on the development of translational

research to improve the diagnosis and treatment of  inherited and acquired

pathologies through modern techniques of genetics, molecular and cellular biology 

 

Groups

Hematopoietic Innovative

Therapies

Cell Technology

Epithelial Biomedicine

Molecular and Translational

Oncology

Outstanding News

A gene therapy clinical trial for patients with Fanconi anemia offers its first successful results

Good preliminary clinical results of the first patient with pyruvate kinase deficiency treated with gene therapy

Gene editing for bullous epidermolysis: closer to the clinic

Development of two lung cancer models with poor prognosis and few therapeutic options